Tubulosine
Tubulosine is an alkaloid. Tubulosine can be isolated from Pogonopus tubulosus (DC.) Schumann. Tubulosine is an ATP-competitive, selective JAK3 inhibitor with an IC50 value of 9.9 nM. Tubulosine also inhibits the kinase activities of other JAK family members, the extent of inhibition is less than that of JAK3, with IC50 values of 69.5, 84.9 and 76.3 nM for JAK1, JAK2 and TYK2, respectively. Tubulosine selectively inhibits JAK3 signalling by binding to the ATP-binding site of the kinase of JAK3. Tubulosine induces apoptotic and necrotic/autophagic cell death. Tubulosine inhibits the process of peptide chain elongation by eukaryotic polysomes by, specifically preventing the elongation-factor-2-dependent step of translocation. Tubulosine exhibits anticancer activity in breast cancer cells.
For research use only. We do not sell to patients.
- CAS No.: 2632-29-3
- Formula: C29H37N3O3
- Molecular Weight:475.62
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
JAK3 9.9 nM (IC50) |
JAK1 69.5 nM (IC50) |
JAK2 84.9 nM (IC50) |
Tyk2 76.3 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | ED50 |
<1*10-5 μg/mL
Compound: 1
|
Cytotoxicity against human A549 cells
Cytotoxicity against human A549 cells
|
[PMID: 1982768] |
| A549 | ED50 |
1 10'-5μg/ml
Compound: 1
|
Cytotoxicity against human A549 cells
Cytotoxicity against human A549 cells
|
[PMID: 1982768] |
| A549 | IC50 |
2.1 μM
Compound: 12
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 31513408] |
| BC1 cell line | ED50 |
0.1 μg/mL
Compound: 2
|
Cytotoxicity against human BC1 cells
Cytotoxicity against human BC1 cells
|
[PMID: 10514334] |
| Col2 | ED50 |
0.05 μg/mL
Compound: 2
|
Cytotoxicity against human Col2 cells
Cytotoxicity against human Col2 cells
|
[PMID: 10514334] |
| HeLa | IC50 |
>10 μM
Compound: 12
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 31513408] |
| HT-29 | ED50 |
<1*10-5 μg/mL
Compound: 1
|
Cytotoxicity against human HT-29 cells
Cytotoxicity against human HT-29 cells
|
[PMID: 1982768] |
| KB | ED50 |
<0.16 μg/mL
Compound: 2
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 10514334] |
| KB | ED50 |
0.1 μg/mL
Compound: 2
|
Cytotoxicity against human multidrug resistant KB cells in absence of vinblastine
Cytotoxicity against human multidrug resistant KB cells in absence of vinblastine
|
[PMID: 10514334] |
| LNCaP | ED50 |
<0.16 μg/mL
Compound: 2
|
Cytotoxicity against human LNCAP cells
Cytotoxicity against human LNCAP cells
|
[PMID: 10514334] |
| Lu1 | ED50 |
<0.001 μg/mL
Compound: 2
|
Cytotoxicity against human Lu1 cells
Cytotoxicity against human Lu1 cells
|
[PMID: 10514334] |
| M109 | ED50 |
0.1 μg/mL
Compound: 2
|
Cytotoxicity against mouse M109 cells
Cytotoxicity against mouse M109 cells
|
[PMID: 10514334] |
| MCF7 | ED50 |
<1*10-5 μg/mL
Compound: 1
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 1982768] |
| SK-N-SH | ED50 |
0.1 μg/mL
Compound: 2
|
Cytotoxicity against human SK-N-SH cells
Cytotoxicity against human SK-N-SH cells
|
[PMID: 10514334] |
| SK-OV-3 | IC50 |
0.4 μM
Compound: 12
|
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 31513408] |
| SW626 | ED50 |
0.22 μg/mL
Compound: 2
|
Cytotoxicity against human SW626 cells
Cytotoxicity against human SW626 cells
|
[PMID: 10514334] |
Chemical Information
-
CAS No. 2632-29-3
-
Molecular Weight 475.62
-
Formula C29H37N3O3
-
SMILES
OC1=CC=C(N2)C(C(CCN3)=C2[C@H]3C[C@H]4C[C@@]5([H])C6=CC(OC)=C(OC)C=C6CCN5C[C@@H]4CC)=C1
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[2]. Carrasco L, et al. Specific inhibition of translocation by tubulosine in eukaryotic polysomes. Eur J Biochem. 1976 Apr 15;64(1):1-5. [Content Brief]
[3]. Kim BH , et al. Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling. J Breast Cancer. 2019 Sep;22(3):362-374. [Content Brief]
[4]. Kim BH, et al. Tubulosine selectively inhibits JAK3 signalling by binding to the ATP-binding site of the kinase of JAK3. J Cell Mol Med. 2020 Jul;24(13):7427-7438. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)